177 related articles for article (PubMed ID: 19342626)
21. Analysis of HLA-E expression in human tumors.
Marín R; Ruiz-Cabello F; Pedrinaci S; Méndez R; Jiménez P; Geraghty DE; Garrido F
Immunogenetics; 2003 Feb; 54(11):767-75. PubMed ID: 12618909
[TBL] [Abstract][Full Text] [Related]
22. Recognition events that inhibit and activate natural killer cells.
Raulet DH
Curr Opin Immunol; 1996 Jun; 8(3):372-7. PubMed ID: 8793997
[TBL] [Abstract][Full Text] [Related]
23. [Expression of NKG2D ligands in multidrug-resistant nasopharyngeal carcinoma cell line CNE2/DDP and their effects on cytotoxicity of natural killer cells].
Mei JZ; Guo KY; Wei HM; Song CY
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jun; 27(6):887-9. PubMed ID: 17584663
[TBL] [Abstract][Full Text] [Related]
24. Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells.
Banerjee P; Feuer G; Barker E
J Virol; 2007 Sep; 81(18):9707-17. PubMed ID: 17609265
[TBL] [Abstract][Full Text] [Related]
25. Human leukocyte antigen class I expression on squamous cell carcinoma cells regulates natural killer cell activity.
Lutz CT; Kurago ZB
Cancer Res; 1999 Nov; 59(22):5793-9. PubMed ID: 10582701
[TBL] [Abstract][Full Text] [Related]
26. Distinct effects of interferon-gamma and MHC class I surface antigen levels on resistance of the K562 tumor cell line to natural killer-mediated lysis.
Maziarz RT; Mentzer SJ; Burakoff SJ; Faller DV
Cell Immunol; 1990 Oct; 130(2):329-38. PubMed ID: 2119892
[TBL] [Abstract][Full Text] [Related]
27. Bortezomib down-regulates the cell-surface expression of HLA class I and enhances natural killer cell-mediated lysis of myeloma.
Shi J; Tricot GJ; Garg TK; Malaviarachchi PA; Szmania SM; Kellum RE; Storrie B; Mulder A; Shaughnessy JD; Barlogie B; van Rhee F
Blood; 2008 Feb; 111(3):1309-17. PubMed ID: 17947507
[TBL] [Abstract][Full Text] [Related]
28. Reduction in susceptibility to natural killer cell-mediated lysis of human FO-1 melanoma cells after induction of HLA class I antigen expression by transfection with B2m gene.
Maio M; Altomonte M; Tatake R; Zeff RA; Ferrone S
J Clin Invest; 1991 Jul; 88(1):282-9. PubMed ID: 1905328
[TBL] [Abstract][Full Text] [Related]
29. p40 molecule regulates NK cell activation mediated by NK receptors for HLA class I antigens and TCR-mediated triggering of T lymphocytes.
Poggi A; Tomasello E; Revello V; Nanni L; Costa P; Moretta L
Int Immunol; 1997 Sep; 9(9):1271-9. PubMed ID: 9310830
[TBL] [Abstract][Full Text] [Related]
30. Involvement of HLA class I alleles in natural killer (NK) cell-specific functions: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2).
Ciccone E; Pende D; Viale O; Than A; Di Donato C; Orengo AM; Biassoni R; Verdiani S; Amoroso A; Moretta A
J Exp Med; 1992 Oct; 176(4):963-71. PubMed ID: 1328466
[TBL] [Abstract][Full Text] [Related]
31. The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors?
Rouas-Freiss N; Marchal RE; Kirszenbaum M; Dausset J; Carosella ED
Proc Natl Acad Sci U S A; 1997 May; 94(10):5249-54. PubMed ID: 9144223
[TBL] [Abstract][Full Text] [Related]
32. Blockade of natural killer cell-mediated lysis by NCAM140 expressed on tumor cells.
Jarahian M; Watzl C; Issa Y; Altevogt P; Momburg F
Int J Cancer; 2007 Jun; 120(12):2625-34. PubMed ID: 17294447
[TBL] [Abstract][Full Text] [Related]
33. A bird's eye view of NK cell receptor interactions with their MHC class I ligands.
Saunders PM; Vivian JP; O'Connor GM; Sullivan LC; Pymm P; Rossjohn J; Brooks AG
Immunol Rev; 2015 Sep; 267(1):148-66. PubMed ID: 26284476
[TBL] [Abstract][Full Text] [Related]
34. Myeloma cells resistance to NK cell lysis mainly involves an HLA class I-dependent mechanism.
Gao M; Gao L; Yang G; Tao Y; Hou J; Xu H; Hu X; Han Y; Zhang Q; Zhan F; Wu X; Shi J
Acta Biochim Biophys Sin (Shanghai); 2014 Jul; 46(7):597-604. PubMed ID: 24850305
[TBL] [Abstract][Full Text] [Related]
35. MICA triggering signal for NK cell tumor lysis is counteracted by HLA-G1-mediated inhibitory signal.
Menier C; Riteau B; Carosella ED; Rouas-Freiss N
Int J Cancer; 2002 Jul; 100(1):63-70. PubMed ID: 12115588
[TBL] [Abstract][Full Text] [Related]
36. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
[TBL] [Abstract][Full Text] [Related]
37. Blastocyst MHC, a putative murine homologue of HLA-G, protects TAP-deficient tumor cells from natural killer cell-mediated rejection in vivo.
Tajima A; Tanaka T; Ebata T; Takeda K; Kawasaki A; Kelly JM; Darcy PK; Vance RE; Raulet DH; Kinoshita K; Okumura K; Smyth MJ; Yagita H
J Immunol; 2003 Aug; 171(4):1715-21. PubMed ID: 12902470
[TBL] [Abstract][Full Text] [Related]
38. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL.
Bakker AB; Phillips JH; Figdor CG; Lanier LL
J Immunol; 1998 Jun; 160(11):5239-45. PubMed ID: 9605119
[TBL] [Abstract][Full Text] [Related]
39. Carfilzomib enhances natural killer cell-mediated lysis of myeloma linked with decreasing expression of HLA class I.
Yang G; Gao M; Zhang Y; Kong Y; Gao L; Tao Y; Han Y; Wu H; Meng X; Xu H; Zhan F; Wu X; Shi J
Oncotarget; 2015 Sep; 6(29):26982-94. PubMed ID: 26323098
[TBL] [Abstract][Full Text] [Related]
40. Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin.
Pende D; Cantoni C; Rivera P; Vitale M; Castriconi R; Marcenaro S; Nanni M; Biassoni R; Bottino C; Moretta A; Moretta L
Eur J Immunol; 2001 Apr; 31(4):1076-86. PubMed ID: 11298332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]